Mold Exposure (Credit: Canva)
Mold is a type of fungus that has been found on the surface of the earth for millions of years. They can get inside your home through open doors, windows, and air conditioning systems. Inhaling mold spores or coming into contact with mold can have severe adverse effects on your health. Beyond physical symptoms like headache and allergic symptoms, it can have a significant impact on the brain and nervous system. Symptoms may vary, from mild headaches to more severe issues like memory loss or difficulty walking. While it can affect anybody, certain groups like children, the elderly, pregnant women, and those with weakened immune systems are particularly vulnerable to these effects.
How can mold impact your neurological health?
Mold, such as Cladophialophora bantiana, can cause infections in the brain and spinal cord, leading to serious conditions like central nervous system (CNS) infections. While such infections are rare, they can be life-threatening.
Mycotoxins are toxic chemicals produced by certain mold types. These toxins can be released into the air when mold grows indoors, and breathing them in can have direct harmful effects on brain function. Studies indicate that mycotoxins may interfere with the nervous system’s communication pathways, leading to cognitive issues such as memory problems and mood swings.
In fact, long exposure to mold can lead to a variety of neurological symptoms, which can differ depending on an individual’s health and the severity of the mold exposure. Some of them are:
Headaches are one of the most frequent symptoms of mold exposure. While most of the time, these headaches are described as dull, constant, or pressure-like, they can sometimes mimic migraines, accompanied by nausea or sensitivity to light and sound.
Exposure to molds can also trigger seizures. Mold produces toxic substances like mycotoxins that may disrupt the brain’s electrical activity, leading to seizure episodes.
Mold exposure can cause brain fog, which results in concentration, memory, and mental clarity. Studies suggest that mycotoxins can disrupt normal brain function, making it challenging to process information and think clearly.
Exposure to this fungus can also lead to emotional problems. People with this kind of exposure have complained of anxiety, depression, irritability, and sudden mood swings. This could be due to mold toxins interfering with brain chemicals responsible for regulating emotions.
Mold exposure may trigger inflammation, leading to muscle and joint pain. In case of prolonged exposure, it could lead to the development or worsening of fibromyalgia or complex regional pain syndrome (CRPS).
In some cases, mold exposure may lead to tremors, difficulty walking, or problems with muscle coordination. These issues may be linked to mycotoxins affecting the brain or nervous system.
Mold exposure can impact the brain areas responsible for movement and balance, making it harder to stand, walk, or perform fine motor tasks. Individuals may feel unsteady or experience difficulty using devices like phones or computers.
Delirium is a condition wherein a person experiences confusion or disorientation. An abnormal immune response to mold could contribute to this condition. Delirium can make it difficult for individuals to think clearly or understand their surroundings.
Credit: AI
Liver disease is unusual among serious conditions in that it can progress significantly without producing symptoms that would prompt most people to seek medical attention. Hepatitis, which is inflammation of the liver, is the most common starting point for that progression.
It may be caused by viral infections including Hepatitis B and Hepatitis C, excessive alcohol consumption, fatty liver disease, certain medications, or autoimmune conditions. In many cases, the person carrying it feels entirely well while damage accumulates over months and years.
The liver does regenerate, but that capacity has limits. When inflammation persists, healthy liver cells are progressively replaced by scar tissue, a process called fibrosis.
Continued scarring eventually produces cirrhosis, where the liver loses its structural integrity and its ability to perform the functions the body depends on it for, such as processing toxins, producing proteins involved in blood clotting, regulating metabolism, and supporting digestion. At this stage, the damage is largely irreversible.
The timeline from hepatitis to cirrhosis typically spans years or even decades, which is precisely what makes delayed diagnosis so consequential. Each year of untreated inflammation is a year of accumulated scarring.
By the time cirrhosis produces obvious symptoms such as jaundice, abdominal swelling from fluid accumulation, internal bleeding from enlarged veins in the oesophagus, cognitive changes from toxin build-up, kidney involvement, the disease has already reached an advanced stage. Cirrhosis also carries a significantly elevated risk of liver cancer.
The clinical picture is meaningfully better when liver disease is identified early. Effective antiviral medications can control chronic Hepatitis B and cure most cases of Hepatitis C, substantially reducing the risk of progression.
Fatty liver disease, when caught before significant fibrosis has occurred, can often be reversed through weight management, blood sugar control, reduced alcohol intake, and consistent physical activity. These interventions are accessible, evidence-based changes that work when applied before the disease has advanced.
Screening is where early identification happens. Blood tests measuring liver enzymes and imaging studies can detect liver inflammation and early fibrosis well before symptoms appear.
For individuals with diabetes, obesity, a family history of liver disease, a history of blood transfusions, or other known risk factors, periodic liver assessment is a practical and important part of routine care rather than an optional precaution.
The pattern that gastroenterologists consistently encounter is patients presenting with advanced liver disease who had risk factors identifiable years earlier. Hepatitis B and C are both detectable through simple blood tests.
Fatty liver shows up clearly on ultrasound. The window for effective intervention exists, and it is considerably wider earlier in the disease than most people assume when they have never been tested.
This draws attention to a disease that carries a substantial global burden but remains widely undertreated because it does not announce itself. For anyone with known risk factors, or who has never had their liver function assessed, the appropriate response to that is a conversation with a physician, before symptoms, rather than after.
By Dr. Saswata Chatterjee, Senior Consultant – Gastroenterology, CMRI Hospital
Credit: AI
Smoking, diabetes, high blood pressure, high cholesterol, and obesity have always been recognized as major risk factors for heart disease.
New research has emerged saying these preventable conditions may do more harm than simply contribute to plaque buildup in the arteries. They may also encourage the formation of the most dangerous type of plaque, the kind that is most likely to rupture and trigger a massive heart attack.
The findings, presented at the European Society of Cardiology (ESC) Congress 2026, show that people with a greater number of modifiable cardiovascular risk factors were more likely to have widespread coronary plaque.
They may also have unstable and vulnerable plaques that can suddenly rupture, disrupting blood flow to the heart.
Researchers analyzed coronary artery imaging data to understand how both modifiable and non-modifiable cardiovascular risk factors affect the characteristics of plaque.
The study found that patients with a higher burden of modifiable risk factors had plaques distributed across all three major coronary arteries.
More importantly, these individuals were more likely to develop lipid-rich plaques with thin fibrous caps, a trait of vulnerable plaques that are more likely to rupture.
On the other hand, people whose risk profile was dominated by non-modifiable factors, such as age or genetics, tended to have more stable plaque types.
"Our findings suggest that modifiable cardiovascular risk factors are associated not only with a greater amount of coronary plaque but also with more vulnerable plaque characteristics that are linked to future heart attacks," the researchers said.
Some plaques gradually harden and remain relatively stable for years, causing slow narrowing of the arteries. Others contain large amounts of fat covered by a very thin protective layer known as a fibrous cap.
These unstable plaques can rupture unexpectedly, prompting blood clots to form and suddenly block an artery, leading to a heart attack or stroke.
According to the researchers, individuals with multiple preventable cardiovascular risk factors were significantly more likely to have these high-risk plaques.
Smoking chronically damages the inner lining of blood vessels, making it easier for cholesterol deposits to accumulate while also promoting inflammation and blood clot formation.
High blood pressure places constant stress on artery walls, accelerating plaque development and increasing the likelihood of rupture.
When several of these risk factors occur together, their harmful effects can compound, increasing both the quantity of plaque and likelihood to rupture.
Also read: Vapers & Smokers Have Equally Poor Physical Fitness & Blood Vessel Health, Study Finds
Atherosclerosis is a chronic condition in which fatty deposits made up of cholesterol, inflammatory cells, calcium, and other substances accumulate inside artery walls.
Over time, these deposits narrow the arteries and reduce blood flow to vital organs. The condition often develops silently over decades before causing symptoms.
If a plaque ruptures, a blood clot can rapidly block blood flow, resulting in a heart attack or stroke. Smoking, diabetes, high blood pressure, obesity, and elevated LDL ("bad") cholesterol are among its leading preventable causes.
The researchers said the study highlights the importance of early identification and management of modifiable cardiovascular risk factors through smoking cessation, blood pressure control, diabetes management, cholesterol-lowering treatment, regular physical activity, a healthy diet, and maintaining a healthy weight.
Credit: AI
Sleep disturbances are among the most debilitating symptoms of Alzheimer’s disease. It often appears years before significant memory decline and other symptoms.
A new study from researchers at the University of Kentucky suggests that this sleep loss may not be permanent.
Instead, it could be driven by an immune response in the brain that may be reversible, sparking hope for new treatments.
Published in the journal Alzheimer’s & Dementia, the study found that brain immune cells called microglia, rather than amyloid plaques themselves, are the primary cause of sleep disruption in Alzheimer’s disease.
In mouse-based trials, researchers were able to restore more than two hours of sleep per day by temporarily removing these immune cells, without reducing amyloid plaques.
For years, scientists believed that sleep problems in Alzheimer’s were caused by the accumulation of amyloid plaques or the gradual death of brain cells. However, this study points in a different direction.
Researchers discovered that when amyloid plaques begin forming in the brain, they activate microglia, the brain’s resident immune cells.
Instead of protecting the brain, these cells cause inflammation that keeps brain circuits active, preventing sleep.
Using a drug called pexidartinib (PLX3397), the researchers temporarily depleted around 87% of microglia in Alzheimer’s mouse models.
This restored over two hours of daily sleep, particularly non-rapid eye movement (NREM) sleep, which is essential for tissue repair, memory strengthening, and clearing waste products from the brain.
Notably, the improvement occurred without changing amyloid plaque levels, suggesting that inflammation is manageable.
Lead researcher Dr. Shannon L. Macauley, associate professor of physiology at the University of Kentucky College of Medicine, said, “Basically, we showed that it is not the plaques themselves, or solely dysfunctional neurons, that cause sleep loss but actually microglia.
Microglia are immune cells that, when they respond to plaques, kick off this elaborate cascade of inflammation, as if the microglia are partying all night, and keeping the brain awake.”
She also highlighted why losing restorative sleep can accelerate disease progression.
“That restorative sleep is super important for physical repair, learning and memory and washing out the toxins of the day. When Alzheimer’s patients lose this stage, they lose their brain’s primary cleaning cycle, creating a feed-forward loop that may drive further damage,” she explained.
First author Dr. Nicholas J. Constantino said one of the biggest surprises was that sleep problems did not worsen as amyloid plaques increased.
“I expected that as plaque burden became more severe, sleep disruption would also worsen. The disruptions in sleep… did not worsen by 18 months, despite more than double the amount of plaque burden,” Constantino said.
Also read: What Is Type 3 Diabetes? Insulin Resistance In The Brain That Could Trigger Alzheimer’s
Poor sleep and Alzheimer’s create a vicious cycle. Sleep deprivation reduces the brain’s ability to clear amyloid-beta and tau proteins, which can accelerate disease progression, while worsening sleep.
Sleep disturbances affect up to half of people living with Alzheimer’s disease. The disease disrupts sleep due to various reasons:
Overactive microglia: As shown in the new study, immune cells become chronically activated by amyloid plaques, releasing inflammatory signals that keep the brain in a heightened state of activity.
Damage to sleep-regulating brain regions: Alzheimer’s progressively affects areas like the hypothalamus and brainstem that regulate the sleep-wake cycle.
Loss of NREM sleep: Due to lack of deep sleep, the brain’s ability to clear metabolic waste, including amyloid plagues weakens.
Circadian rhythm disruption: Degeneration of the brain’s internal clock leads to broken sleep and daytime drowsiness. This fuels confusion and agitation associated with the disease.
© 2024 Bennett, Coleman & Company Limited